Logo

REPEAT: Feb 1, 2001

Feb 01, 2001
Premium

“The only intellectually honest position would be to not publish the [Celera] paper. If it came to me, I would simply chuck it in the bin without even opening the FedEx package.”

— Michael Ashburner, Professor of Biology, Department of Genetics, University of Cambridge, and Joint-Head, European Bioinformatics Institute

Breaking News
The Scan

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.